[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization

J Biol Chem. 2011 May 6;286(18):16229-37. doi: 10.1074/jbc.M110.204701. Epub 2011 Mar 23.

Abstract

In this study, we describe a new method for inducing choroidal neovascularization (CNV) in C57BL/6 mice, an animal model of wet age-related macular degeneration (AMD). AMD is a disease that causes central blindness in humans. We injected PEG-8 subretinally in different doses (0.125-2 mg) to induce CNV. After PEG-8 injection, we examined CNV at several time points (days 3-42). We also used Western blotting, immunohistochemistry, and ELISA to examine the complement component C3 split products, C9, VEGF, TGF-β2, and basic FGF. As early as day 1 after treatment, we found that a single subretinal injection of 1 mg of PEG-8 increased the C3 split products and the C9, TGF-β2, and basic FGF levels in the retinal pigment epithelium-choroid tissue. By day 3 after PEG-8 injection, the intraocular activation of the complement system caused induction and progression of CNV, including new vessels penetrating the Bruch's membrane. At day 5 after PEG-8 injection, we observed a fully developed CNV and retinal degeneration. Thus, in this study, we present a new, inexpensive, and accelerated mouse model of CNV that may be useful to study AMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Choroidal Neovascularization / chemically induced*
  • Choroidal Neovascularization / metabolism
  • Choroidal Neovascularization / pathology
  • Complement C3 / metabolism
  • Complement C9 / metabolism
  • Disease Models, Animal*
  • Drug Carriers / adverse effects*
  • Drug Carriers / pharmacology
  • Macular Degeneration*
  • Mice
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / pharmacology
  • Time Factors
  • Transforming Growth Factor beta2 / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Complement C3
  • Complement C9
  • Drug Carriers
  • Tgfb2 protein, mouse
  • Transforming Growth Factor beta2
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
  • Polyethylene Glycols